Cargando…

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Baak, Jan P. A., Kruse, Arnold-Jan, Janssen, Emiel, van Diermen, Bianca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2005
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615954/ http://dx.doi.org/10.1155/2005/351460

Ejemplares similares

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Kruse, Arnold-Jan, et al.
Publicado: (2004)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Silvestrini, Rosella
Publicado: (2005)

Predictive Testing of Early CIN Behaviour by Molecular Biomarkers
por: Baak, Jan P. A., et al.
Publicado: (2005)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

A protein profile study to discriminate CIN lesions from normal cervical epithelium
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
por: Lillesand, Melinda, et al.
Publicado: (2020)

In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”
por: Belderbos, Robert A., et al.
Publicado: (2021)

Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2021)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Clinical validity and clinical utility of Ki67 in early breast cancer
por: Kreipe, Hans, et al.
Publicado: (2022)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions
por: van Zummeren, Marjolein, et al.
Publicado: (2018)

Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting
por: Bulloni, Matteo, et al.
Publicado: (2021)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The progress in our understanding of CIN in breast cancer research
por: Liao, Yu-Yang, et al.
Publicado: (2023)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

The Relationship between Syntactic Structure Analysis Features, Histological Grade and High-Risk HPV DNA in Cervical Intraepithelial Neoplasia
por: Kruse, Arnold‐Jan, et al.
Publicado: (2004)

P16INK4a/ki67 Immunocytochemistry in Improving the Predictive Value for High Grade Cervical Intraepithelial (≥CIN2) Neoplasia in Pap Smear
por: Kumar, G Vinoth, et al.
Publicado: (2021)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

Meiotic-Like Division to a Aneuploidy: Chromosomal Instability (CIN), Cell-Senescence and Cancer
por: Walen, Kirsten H.
Publicado: (2008)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial
por: Major, Attila Louis, et al.
Publicado: (2020)

Uterine leiomyosarcoma in a wild rat (Rattus norvegicus): usefulness of Ki-67 labeling index for diagnosis
por: Jeon, Byung-Suk, et al.
Publicado: (2013)

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
por: Magnusson, Kristina, et al.
Publicado: (2016)

Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence
por: Ziaran, Stanislav, et al.
Publicado: (2020)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

KI and WU Polyomaviruses in Children, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ufdum6mg979gp9oq6s6kt0h91b